British Columbia's Human Rights Commissioner says the province is worsening the toxic drug crisis by treating substance use as “moral failings” or a criminal problem, and says the approach is a ...
A CORONER has raised concerns about drugs getting into HMP Berwyn following the death of an inmate. Matthew Lucas Sundeep Singh, aged 26, died at the Wrexham prison on November 23, 2019.
As deadly drug overdoses climbed across Canada, decision-makers faced political backlash for funding programs that gave drug ...
Investor's Business Daily on MSN
Stock Market Today: Dow Climbs Off Lows; Drug Stock Doubles On Merck Deal (Live Coverage)
The Dow Jones industrials still held a loss of 0.3% after the index pared a steeper loss. Blue-chip stocks like Nvidia NVDA, ...
The Cut on MSN
‘I Thought It Was the Safest Option’
Parents are panicking after ByHeart recalled all its premium formula products and 15 babies were hospitalized with botulism.
General and administrative expenses increased by approximately $63 thousand (5%) during the three months ended September 30, 2025, compared to the three months ended September 30, 2024. The increase ...
FDA Type 2a meeting scheduled for November 19, 2025, to review AEON’s analytical development plan and initial data –– Positive biosimilarity ...
Q3 2025 Earnings Call Transcript November 13, 2025Protalix BioTherapeutics, Inc. misses on earnings expectations.
Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three and nine ...
Why Am I Not Losing Weight on Wegovy®? How to Get Results Key takeaways: Not losing weight on Wegovy® could be due to dose, ...
Zelsuvmi received a Novel Drug designation from the FDA in January 2024 and is the first and only prescription therapy approved for use at home by patients, parents, and caregivers to treat molluscum ...
DARE to PLAY Sildenafil Cream on Track to Launch Before Year End via 503B Pathway, Paving the Way for Near-Term Product RevenuePositive Interim DSMB Outcome for Ovaprene® Phase 3 Study Supports Contin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results